Bicifadine: Nonopioid analgesic norepinephrine transporter inhibitor serotonin transporter inhibitor NMDA antagonist

Drugs of the Future

Volumn 30, Issue 1, 2005, Pages 7-10

  Sorbera, L A ^a   Castaner J ^a   Leeson, P A ^a  

^a PROUS SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; BICIFADINE; CANNABINOID; CODEINE; CYCLOOXYGENASE 2 INHIBITOR; DEXTROPROPOXYPHENE; GABAERGIC RECEPTOR AFFECTING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITRIC OXIDE SYNTHASE INHIBITOR; NOCICEPTIN RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN UPTAKE INHIBITOR; OPIATE; PENTAZOCINE; PHOSPHOLIPASE A2 INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SUPEROXIDE DISMUTASE; TRAMADOL;

ARTICLE; CHRONIC PAIN; CLINICAL TRIAL; DIAPHORESIS; DIZZINESS; DROWSINESS; DRUG DEPENDENCE; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DRUG SYNTHESIS; DRUG TOLERANCE; HUMAN; IN VIVO STUDY; LONG TERM CARE; LOW BACK PAIN; NONHUMAN; PAIN; POSTOPERATIVE PAIN; SIDE EFFECT; TOOTH PAIN; VOMITING;

EID: 14944378848     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2005.030.01.871476     Document Type: Article

References (17)

1. Fanshawe, W.J., Epstein, J.W., Crawley, L.S., Hofmann, C.M., Safir, S.R. (Wyeth). Azabicyclohexanes and process for their preparation. BE 0858683, DE 2740562, FR 2375212, JP 1978037656.
2. Epstein, J.W., Brabander, H.J., Fanshawe, W.J., Hofmann, C.M., McKenzie, T.C., Safir, S.R., Osterberg, A.C., Cosulich, D.B., Lovell, F.M. 1-Aryl-3-azabicyclo[3.1.0]hexanes, a new series of nonnarcotic analgesic agents. J Med Chem 1981, 24: 481-90.
3. Prous Science Drug R&D Backgrounders: Pain (online publication). Updated January 19, 2005.
4. Ballantyne, J.C., Mao, J. Opioid therapy for chronic pain. New Engl J Med 2003, 349: 1943-53.
5. McQuay, H. Opioids in pain management. Lancet 2001, 357(Suppl. 1): 37.
6. Ashburn, M.A., Staats, P.S. Management of chronic pain. Lancet 2001, 357(Suppl. 1): 24.
7. Epstein, J.W., Osterberg, A.C., Regan, B.A. Bicifadine: Nonnarcotic analgesic activity of 1-aryl-3-azabicyclo[3.1.0]hexanes. NIDA Res Monogr 1982, 41: 93-8.
8. 3H]imipramine and the serotonin transporter in human platelets. J Neurochem 1987, 48: 560-5.
9. Gray, W.D., Osterberg, A.C., Scuto, T.J. Measurement of the analgesic efficacy and potency of pentazocine by the D'Amour and Smith method. J Pharmacol Exp Ther 1970, 172: 154-62.
10. Eddy, N.E., Touchberry, C.F., Lieberman, J.E. Synthetic analgesics; methadone isomers and derivatives. J Pharmacol Exp Ther 1950, 98: 121-37.
11. Saelens, J.K., Granat, F.R., Sawyer, W.K. The mouse jumping test - A simple screening method to estimate the physical dependence capacity of analgesics. Arch Int Pharmacodyn Ther 1971, 190: 213-8.
12. Wang, R.I., Johnson, R.P., Lee, J.C., Waite, E.M. The oral analgesic efficacy of bicifadine hydrochloride in postoperative pain. J Clin Pharmacol 1982, 22: 160-4.
13. Czobor, P., Stark, J., Beer, G., Petti, S., Lippa, A., Brown, J., Beer, B. A double-blind, placebo controlled randomized study of DOV220,075 (bicifadine) SR and codeine 60 mg in the treatment of post-operative dental pain. 22nd Annu Sci Meet Am Pain Soc (March 20-23, Chicago) 2003, Abst 915.
14. Czobor, P., Stark, J., Beer, G. et al. A two center double-blind, placebo-controlled randomized study of DOV 220,075 (bicifadine) SR and tramadol 100 mg in the treatment of post-operative dental pain. 23rd Annu Sci Meet Am Pain Soc (May 6-9, Vancouver) 2004, Abst 801.
15. Bicifadine enters acute pain phase III trial. DailyDrugNews.com (Daily Essentials) Sept 29, 2004.
16. DOV initiates phase III long term safety clinical trial for bicifadine, its novel analgesic. DOV Pharmaceutical Press Release Sept 28, 2004.
17. Long-term safety of bicifadine evaluated in new phase III trial. DailyDrugNews.com (Daily Essentials) Dec 20, 2004.